Setting a new milestone, the Indian government on November 20 launched an indigenous CRISPR-based gene therapy for Sickle Cell Disease, which particularly affects India's tribal population. The ...

GK Quiz Today, 5 December, 2025; Latest Current Affairs Questions & Answers: Daily engagement with GK and current affairs ...

The Minister noted that with the development and transfer of India's first indigenous CRISPR-based gene therapy, the nation is moving closer to fulfilling Prime Minister Narendra Modi's goal of ...

Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...

After releasing two gene-edited rice varieties in May this year, scientists are now focusing on developing GE varieties of ...

A session at the AHA Scientific Sessions 2025 focused on the latest groundbreaking trails in cardiometabolic therapies.

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common illnesses. So far, only 15 people have received the treatment. But, if all ...

We believe BEAM-101 has the potential to be a best-in-class option for the roughly 10% of sickle cell patients, who have ...